Telmijub AM-H 40 Tablet
Marketer
Jubilant Generics Limited
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telmijub AM-H 40 Tablet
Amlodipine/Hydrochlorothiazide 40mg tablets are a dual-action medication prescribed for managing hypertension when monotherapy proves insufficient. This combined therapy effectively reduces elevated blood pressure, mitigating the risk of future cardiovascular events like stroke and heart attack. This medication may be taken with or without food, with dosage tailored to individual response and health status. Consistent daily dosing at the same time is recommended. Continue treatment as directed by your physician; discontinuation may increase stroke or heart attack risk. The formulation includes a diuretic, prompting increased urination; therefore, avoid administration within four hours of bedtime. Regular use is crucial for optimal therapeutic benefit, even in the absence of noticeable symptoms, as hypertension is often asymptomatic. Common side effects can include headache, dizziness, fatigue, altered taste perception, flu-like symptoms, diarrhea, and sinus inflammation. Report persistent, worsening, or bothersome side effects to your doctor immediately. Maintain adequate hydration to counteract potential side effects such as muscle weakness, dry mouth, and thirst. Prior to commencing treatment, inform your doctor of any pre-existing kidney or liver conditions. Pregnant or lactating individuals should seek medical counsel before initiating therapy. Always disclose all current medications, particularly those for hypertension or cardiac conditions. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is essential to ensure treatment efficacy and safety.
Primary Ingredients of Telmijub AM-H 40 Tablet
No text provided. Please provide the text you would like me to rephrase.
Uses of Telmijub AM-H 40 Tablet
Elevated blood pressure
Major Benefits of Telmijub AM-H 40 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Telmijub AM-H 40 Tablet whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistency is key—take it at the same time each day.
Common Side effects of Telmijub AM-H 40 Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telmijub AM-H 40 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmijub AM-H 40 Tablets can be consumed with or without food, though consistent timing is recommended.
How Telmijub AM-H 40 Tablet works:
Telmisartan, amlodipine, and hydrochlorothiazide are combined in Telmijub AM-H 40 Tablet. This triple medication utilizes an angiotensin receptor blocker (telmisartan) and a calcium channel blocker (amlodipine) to dilate blood vessels, thus reducing blood pressure. The diuretic hydrochlorothiazide facilitates fluid and electrolyte excretion via urination, contributing to vasodilation and enhanced circulation over time.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telmijub AM-H 40 Tablet and alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Telmijub AM-H 40 Tablet during pregnancy poses a confirmed risk to the fetus. Its use should only be considered in exceptional, life-threatening circumstances where the potential benefits outweigh the known dangers, and this decision should be made solely by a physician. Patient consultation with a doctor is essential.
Breast feedingUNSAFE
Nursing mothers should avoid Telmijub AM-H 40 Tablets. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving may be impaired by Telmijub AM-H 40 Tablet side effects. These side effects can include dizziness, headache, nausea, or fatigue, potentially impacting concentration and driving ability.
KidneyCAUTION
Individuals with severe kidney impairment should exercise caution when using Telmijub AM-H 40 Tablet, potentially requiring dosage modification. A physician's consultation is advised. Telmijub AM-H 40 Tablet is not recommended for those with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Telmijub AM-H 40 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Telmijub AM-H 40 Tablet :
Should you forget a dose of Telmijub AM-H 40 Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmijub AM-H 40 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |


